TC BioPharm (Holdings) (TC BioPharm (Holdings)) Other Current Liabilities : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Other Current Liabilities?

TC BioPharm (Holdings)'s other current liabilities for the quarter that ended in Mar. 2024 was $0.00 Mil.

TC BioPharm (Holdings)'s quarterly other current liabilities declined from Jun. 2023 ($1.77 Mil) to Dec. 2023 ($0.02 Mil) and declined from Dec. 2023 ($0.02 Mil) to Mar. 2024 ($0.00 Mil).

TC BioPharm (Holdings)'s annual other current liabilities declined from Dec. 2021 ($9.21 Mil) to Dec. 2022 ($7.34 Mil) and declined from Dec. 2022 ($7.34 Mil) to Dec. 2023 ($0.02 Mil).

TC BioPharm (Holdings) Other Current Liabilities Historical Data

The historical data trend for TC BioPharm (Holdings)'s Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Other Current Liabilities Chart

TC BioPharm (Holdings) Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

TC BioPharm (Holdings) Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial							-	-	-	-	-

TC BioPharm (Holdings) Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

TC BioPharm (Holdings) Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

TC BioPharm (Holdings) (TC BioPharm (Holdings)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (NAS:TCBP) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

T0U:Germany

Address

Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR

Website

https://www.tcbiopharm.com

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Executives

Renaissance Capital Partners Ltd	10 percent owner	42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD